Investing

Teva : TEVA

TEVA

Stock Data

$29.79

$0.39 (1.29%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, specializing in the development, manufacture, and distribution of generic and specialty medicines, as well as biopharmaceutical products. With a strong presence in North America, Europe, Israel, and beyond, Teva offers a wide range of medications, including treatments for central nervous system disorders, respiratory conditions, and cancer. The company is also known for its contributions to neurodegenerative and movement disorder treatments, with notable products like COPAXONE for multiple sclerosis and AJOVY for migraine prevention. Founded in 1901 and headquartered in Tel Aviv, Israel, Teva is committed to improving health and making quality healthcare accessible worldwide.

All Teva Articles

450 Articles

Omor Ibne Ehsan | Dec 11, 2025 at 9:11 AM EST

Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been…

William Temple | Dec 6, 2025 at 8:52 AM EST

Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue

Pfizer (NYSE: PFE) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two pharmaceutical companies moving in…

Omor Ibne Ehsan | Nov 24, 2025 at 11:38 AM EST

This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.

Stanley Druckenmiller has been one of the most successful investors, a billionaire with a long record of high returns in…

Joey Frenette | Jul 1, 2025 at 5:20 PM EDT

Billionaire Stanley Druckenmiller Sold Palantir And Bought This Stock Instead

Billionaire investment legend Stanley Druckenmiller is quickly becoming one of my favorite big-money managers to follow quarter to quarter. He’s…

Ian Cooper | Apr 16, 2025 at 11:06 AM EDT

Billionaire Sold Broadcom And Bought This Stock That Could Soar 121%

If you’re looking for solid opportunities, keep an eye on 13F filings. Most times, they offer an under-the-hood look at…

Lee Jackson | Dec 18, 2023 at 9:15 AM EST

4 Can’t Miss Stocks Highlight Monday’s Top Wall Street Upgrades and Downgrades

Monday's top analyst upgrades and downgrades included Arm, General Electric, Micron Technology and Salesforce.

Lee Jackson | Jul 7, 2023 at 8:55 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: American Express, Keurig Dr Pepper, Meta, Teva Pharmaceutical and More

Friday's top analyst upgrades and downgrades included American Express, Aptiv, BorgWarner, First Horizon, Keurig Dr Pepper, Meta Platforms, MGIC Investment,…

Lee Jackson | Jun 24, 2023 at 6:15 AM EDT

5 Well-Known Buy-Rated Stocks Under $10 Could Explode Higher in July

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Lee Jackson | May 27, 2023 at 6:10 AM EDT

5 Very Well Known Buy-Rated Stocks Under $10 Could Explode Higher This Summer

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Lee Jackson | Jan 20, 2023 at 8:45 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Alcoa, Charles Schwab, IBM, Newmont, Philip Morris, Roblox, Shopify, Texas Instruments, Transocean and More

Friday's top analyst upgrades and downgrades included Alcoa, Charles Schwab, Cognizant Technology Solutions, IBM, Newmont, Okta, Philip Morris International, Roblox,…

Chris Lange | Nov 14, 2022 at 11:25 AM EST

Markets Settle Into Retail Earnings: Analysts Upgrade or Downgrade Bank of America, Nio and More

Monday’s additional top analyst upgrades and downgrades were on ASML, Bank of America, Dominion Energy, Hasbro, Nio, Occidental Petroleum, Teva…

Chris Lange | Oct 21, 2022 at 8:54 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AT&T, Exxon Mobil, Hasbro, Moderna, Snap, Under Armour and More

Friday's top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical,…

Chris Lange | Aug 5, 2022 at 10:40 AM EDT

Huge July Employment Report: Analysts Upgrade or Downgrade Duke Energy, Paramount, Teva Pharmaceutical and More

Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and…

Lee Jackson | Aug 3, 2022 at 8:51 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Caterpillar, Ford, Mosaic, Phillips 66, Plug Power, Ross Stores, Uber and More

Wednesday’s top analyst upgrades and downgrades included Bluebird Bio, Caterpillar, Chesapeake Energy, Comstock Resources, Ford, Mosaic, On Semiconductor, Phillips 66,…

Chris Lange | Jun 14, 2022 at 11:35 AM EDT

Waiting for the Fed to Change: Analysts Upgrade or Downgrade Best Buy, Oracle, Teva Pharma and More

Tuesday's additional top analyst upgrades and downgrades were on Adobe, AstraZeneca, Best Buy, Chemours, Oracle, Royalty Pharma, Teva Pharmaceutical and…